Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌：随机、3期研究309/KEYNOTE-775的5年结果
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013713
Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica
